assignment of the wild-type BlaP (BlaP-WT) and of the two reference proteins, BlaP197Q0 and BlaP216Q0, wherein a Pro-Gly dipeptide has been introduced at position 197 and 216, respectively; this dipeptide originates from the addition of the Sma1 restriction site at the genetic level to allow further polyQ sequence insertion.
of even healthy people; however, the former is inherently unstable and tends to expand in successive generations by mutations leading to an increasingly long polyQ sequence. When the length of this polyQ sequence exceeds a threshold characteristic to each disease (generally comprised between 35 and 45 glutamines), it becomes pathogenic by facilitating the aggregation and conversion of the polyQ protein into amyloid fibrils which are deposited in neurons as nuclear inclusions (Orr and Zoghbi 2007; Almeida et al. 2013) . Proteins involved in polyQ diseases have very little in common at the level of sequence, structure or function, except for the presence of the expanded polyQ sequence which is the critical determinant for their amyloid fibril-forming propensity (Almeida et al. 2013) . It has been shown that non-polyQ regions (i.e. folded domains and/or sequences flanking the polyQ tract) play an important modulating role, either facilitative or preventive, in the aggregation process (Robertson and Bottomley 2010) . The underlying principles of how nonpolyQ regions influence polyQ sequences and their ability to induce protein aggregation are not yet fully understood. Disease-associated polyQ proteins cannot be easily handled in vitro due to their large size and/or poor solubility; therefore an alternative strategy to better understand these principles involves the development and characterization of model polyQ proteins whereby a polyQ sequence is inserted into a well-characterized, soluble and easy to handle host protein.
We engineered polyQ model proteins using the β-lactamase from Bacillus licheniformis 749/C referred to as BlaP. BlaP has been chosen as a protein scaffold because: (i) it is a relatively small and stable protein (~ 30 kDa), readily overexpressed in E.coli (Huynen et al. 2013 ); (ii) its threedimensional structure is well-characterized: the protein is composed of two structural domains (an α domain and an α/β domain) at the interface of which the catalytic site is located; and most importantly, (iii) it tolerates peptide insertions at several positions (Vandevenne et al. 2007; Scarafone et al. 2012; Huynen et al. 2013) .
BlaP polyQ-chimeras were created by inserting a polyQ sequence of different lengths (from 23Q to 79Q) at two locations of BlaP, i.e. at position 197 (168) and 216 (187), referred to as 197 and 216 chimeras, respectively. Note that these position numbers correspond to those of standard numbering scheme defined for class A β-lactamases, ABL (Ambler et al. 1991) ; the underlined number appearing here in parentheses corresponds to the number in BlaP sequence. The correspondence between the two numbering systems is given in Table 1 . The ABL numbering has been previously used to describe the characterization of BlaP-based hybrid proteins (Vandevenne et al. 2007; Scarafone et al. 2012; Huynen et al. 2013 Huynen et al. , 2015 and is therefore used here in the introduction and methods sections; in the remainder of the paper dealing with NMR, only the sequence number (underlined number) will be used. Note also that the BlaP protein used to create the polyQ chimeras is the secreted form following complete N-terminal proteolytic processing and therefore starting at position 27 (Vandevenne et al. 2007) (Table 1) .
These two insertion sites were selected based on the following: (i) both sites correspond to permissive insertion sites, e.g. insertion of peptide of various lengths at these positions results in chimeric BlaP proteins that are soluble and functional (Vandevenne et al. 2007 ); (ii) both sites are located in solvent-exposed loops of similar size (4 residues for the 197 loop versus 5 residues for the 216 loop) connecting two α-helices, therefore they have a comparable overall protein context; (iii) while position 197 is situated in a loop within the α-domain, the loop containing position 216 links the α and α/β domains. This distinction allows us to compare the effects of an intradomain (i.e. at position 197) versus those of an interdomain (i.e. at position 216) insertion of a polyQ sequence on the properties of the host protein.
To insert poly(CAG) sequences within the β-lactamase gene, recognition sites for the Sma1 restriction enzyme have been introduced at the location of the insertion (i.e. between sequences coding for the amino acids 197-198 or 216-217) (Scarafone et al. 2012; Thorn et al. in preparation) (Table 1 ). The insertion of this restriction site at the gene level leads to translation of the dipeptide proline-glycine at position 197 and 216 respectively; these proteins are referred to as BlaP197Q0 and BlaP216Q0. By comparison with these two BlaP variants with a Pro-Gly dipeptide inserted at these two positions, we aim to distinguish between the impact of the polyQ repeat and insertions in general.
The aggregation properties of the BlaP polyQ-chimeras are characteristic of proteins associated with polyQ diseases (Scarafone et al. 2012; Thorn et al. in preparation) ; namely: (i) there is a Q-threshold length above which the polyQ sequence triggers the aggregation of proteins into amyloid fibrils, and (ii) above this threshold, the longer the polyQ sequence, the faster the aggregation. Moreover, the aggregation propensity of BlaP-polyQ chimeras depends on the location of the polyQ sequence within BlaP. Interestingly, the 216 chimeras display increased aggregation propensity: indeed (i) the minimum polyQ length leading to aggregation is lower compared to 197 chimeras, and (ii) above threshold length, the aggregation rate is significantly higher than that observed by 197 chimeras with equivalent polyQ lengths. This observation suggests a significant modulating role of the non-polyQ regions (i.e. the BlaP moiety) on the mechanism of aggregation induced by polyQ sequences. Altogether, these results indicate that BlaP-polyQ chimeras are relevant protein models to further investigate (i) how expanded polyQ sequences trigger the aggregation of proteins into amyloid fibrils and (ii) how non-polyQ regions modulate the propensity of polyQ sequences to induce aggregation. The latter may depend on the (local) stability and dynamics of the BlaP moiety within each polyQ chimera; experiments 1 3 such as H/D exchange monitored by NMR are therefore of particular interest. Such work requires the assignment of the [ 1 H-15 N] 2D HSQC spectrum of the BlaP chimeras. Here, we report the NMR assignment of the wild-type BlaP (BlaP-WT) and of the two reference proteins, BlaP197Q0 and BlaP216Q0.
Methods and experiments

Molecular biology
The gene coding for BlaP-WT, BlaP197Q0 and BlaP216Q0 were amplified from the pNYBlaP-WT, pNYBlaP197Q0 and pNYBlaP216Q0 vectors, respectively (Scarafone et al. 2012; Huynen et al. 2015) , with the following primers: 5′-ACA ATT CCC CTC TAG AAA TAA TTT TGT TTA ACT TTA AGA AGG AGA TAT ACC ATG ACG GAG ATG AAA GAT GAT TTT GCA AAAC-3′ and 5′-GAC GGC CAG TGA ATT CTC AGT GGT GGT GGT GGT GGG GCC CTT TCC CGT TCA TGT TTA AGG C-3′. The resulting DNA was then cloned into the pET28b vector containing a kanamycin resistance gene and for which protein expression is inducible by isopropyl β-D-1-thiogalactopyranoside (IPTG) using T7 promoter. In this vector, the BlaP gene is followed by a C-terminal poly(His) 5 tag to facilitate the purification of the protein. A SmaI restriction site has also been introduced into the BlaP variant gene between the trinucleotides coding for residues 197-198 (168-169) or 216-217 (187-188) ; this restriction site is translated into a Pro-Gly dipeptide at position 197-198 (168-169) or 216-217 (187-188) of the protein respectively. The sequence of the three genes cloned into the pET28b vector was checked by the Sanger method at the GIGA GenoTranscriptomics technology platform (Liège, Belgium). These vectors were then used to transform the BL21(DE3) expression strain of E. coli (Novagen, WI, USA).
Expression and purification of 15 N and 13 C double-labeled BlaP and its variants
BlaP-WT and its PG-inserted variants were expressed in E. coli BL21 (DE3) cells and uniformly labeled with 15 N and 13 C. Firstly, cells were grown in 2 L of LB medium containing 50 µg/mL kanamycin at 37 °C under orbital agitation at 250 rpm until the absorbency at 600 nm reached ≈0.7. Cultures were then centrifuged at 2800 g for 5 min (Avanti J-E Centrifuge, Beckman Coulter). Supernatants were discarded and the pellets were resuspended in 500 mL of M9 minimal medium containing 50 µg/mL kanamycin, 2 g 13 C-d-glucose and 0.5 g 15 N-NH 4 Cl as carbon and nitrogen sources, respectively (Cambridge Isotope Laboratory, Andover, USA). After 1 h of incubation at 37 °C under orbital agitation at 250 rpm, protein expression was induced with 1.2 mM IPTG (final concentration). Cell growth was then allowed for a further 3 h of incubation. Cells were harvested by centrifugation (1400 g for 15 min, Avanti J-E Centrifuge, Beckman Coulter) and then resuspended in 100 mL phosphate buffered saline (PBS, 50 mM sodium phosphate, 150 mM NaCl, pH 7.5) containing 2 µL benzonase (Novagen), 2 mM MgCl 2 and 2 tablets of EDTA-free, proteaseinhibitor cocktail (cOmplete™, Roche, Penzberg, Germany). Cells were homogenized using an Ultra-turax homogenizer (IKA T18 basic, VWR, Radnor, Pennsylvania) and lysed by three passages through a French press (Emulsiflex-C3, Avestin, Ottawa) at 1000-1500 bar. The cytoplasmic extract obtained was then centrifuged at 2600 g for 30 min (Avanti J-E Centrifuge, Beckman Coulter) and the supernatant successively filtered through a 0.7 and 0.45 µm cut-off pore membrane. BlaP-WT and its variants were purified by nickel affinity chromatography as previously described (Scarafone et al. 2012) . Fractions of elution containing more than 95% of proteins of interest, as assessed by SDS-PAGE and densitometry analysis, were pooled and dialyzed twice against 15 L of 20 mM sodium phosphate, 50 mM NaCl, pH 6.5. The protein concentration was determined by measuring the absorbance at 280 nm using a molar extinction coefficient value of 33,000 M − 1 cm − 1 (Scarafone et al. 2012 ) and proteins were stored at −20 °C.
NMR spectroscopy
NMR experiments were acquired at 308 K using 15 N-13 C double-labeled protein concentrated to 500-800 µM in 20 mM sodium phosphate, 50 mM NaCl, pH 6. . Data of BlaP-WT and BlaP197Q0 were processed using Topspin (version 2.1, Bruker BioSpin GmbH, Germany) and analyzed using CCPNMR (Vranken et al. 2005) . Data for BlaP216Q0 were processed using NMRPipe (Delaglio et al. 1995) and analyzed using Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco). All NMR spectra were referenced by assigning to 0 ppm the hydrogen frequency of DSS and using the indirect referencing method described by Wishart et al. (1995) . 
Extent of assignment and data deposition
BlaP-WT comprises 265 residues (excluding the poly(His) 5 tag and the preceding proline residue introduced with the tag), while the BlaP197Q0 and BlaP216Q0 variants are composed of 267 residues due to the addition of the ProGly dipeptide (Table 1) . Despite the size of the proteins (30 kDa), the HSQC spectra of the three proteins are welldispersed owing to their folded structure and α/β content. Figure 1 shows the [ 1 H-15 N] 2D HSQC spectrum of BlaP-WT. A total of 98.8% (excluding the 11 prolines) of the expected backbone 1 H-15 N correlations were assigned; corresponding to 251 out of 254 residues. Moreover, 94.4% of the C α were assigned. Missing assignments (i.e. residues for which no corresponding resonance was observed) include the two first residues belonging to the N-terminus (T1 & E2) and A208. The chemical shift assignments for BlaP-WT have been deposited in the BioMagResBank (http://www. bmrb.wisc.edu) under the accession number 25821.
BlaP-WT
BlaP197Q0
Figure 2 shows the [ 1 H-15 N] 2D HSQC spectrum of BlaP197Q0. A total of 95.3% of the 'assignable' backbone 1 H-15 N correlations (i.e. excluding the 12 prolines) were assigned; corresponding to 243 out of 255 residues. Moreover 95.1% C α , 95.2% C β and 95.1% C ' were also assigned. Missing assignments include the two residues belonging to the N-terminus (T1 & E2), A163, A165, all residues juxtaposing the insertion site D168 from E167 to L172 inclusive, A210 and D242. The chemical shift assignments for BlaP197Q0 have been deposited in the BioMagResBank were also assigned. Missing assignments include the first residues belonging to the N-terminus (T1 & E2), R195 and D242. In contrast with the BlaP197Q0 assignment, it was possible to assign residues juxtaposing the insertion site T187. The chemical shift assignments for BlaP216Q0 have been deposited in the BioMagResBank (http://www.bmrb.wisc.edu) under the accession number 25003.
For all three proteins, the backbone amides belonging to the two N-terminal residues (i.e. T1 & E2) were not observed due to rapid hydrogen exchange with the solvent at neutral pH (Bundi and Wüthrich 1977) . Likewise, complete backbone assignment in the flexible and exposed intradomain loop encompassing the 168 insertion site (i.e. between α-helices 8 and 9) was challenging, particularly following dipeptide (Pro-Gly) insertion at this site, as suggested by the high number of missing assignments in BlaP197Q0 within this region, i.e. residues E167 to L172. Interestingly, it was possible to assign residues on the interdomain loop encompassing the 187 insertion site even after dipeptide insertion. Signals for residues E167-L172 are likely too broadened to be observed due to an unfavourable intermediate exchange regime. On the contrary, residues juxtaposing the 187 insertion site in BlaP216Q0, e.g. residues T187 to G190, are readily observed in the HSQC spectrum of the protein, thereby excluding an intermediate conformational exchange regime.
